These studies suggested that TDO2-expressing cancer cells escape immune surveillance by activating AhR in various immune cells including dendritic cells, macrophages, natural killer cells, innate lymphoid cells, Tc cells, and Tregs cells [108,109]. The gene discussed is AHR; the disease is cancer.